FDA Drug recall D-0327-2024
Oseltamivir Phosphate for Oral Suspension 6mg/ml, 60 mL (reconstituted) bottle, RX only, Distributed by Amneal Pharmaceuticals LLC, Bridgew…
- FDA Drug
- Class II
- terminated
- Published 2024-02-28
On 2024-02-28 the FDA classified a Class II recall of Oseltamivir Phosphate for Oral Suspension 6mg/ml, 60 mL (reconstituted) bottle, RX only, Distributed by Amneal Pharmaceuticals LLC, Bridgew… by Amneal Pharmaceuticals, citing failed Impurities/Degradation Specifications: Out-of-specification test results.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0327-2024 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2024-02-13 |
| Published | 2024-02-28 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Amneal Pharmaceuticals |
| Distribution | US |
Product
Oseltamivir Phosphate for Oral Suspension 6mg/ml, 60 mL (reconstituted) bottle, RX only, Distributed by Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807. NDC# 69238-1273-6
Reason
Failed Impurities/Degradation Specifications: Out-of-specification test results.
Identifiers
| ndc | 69238-1273-6 |
|---|---|
| code_info | Lot # BF22722A, Exp. 08/31/2024; BJ15122A, Exp. 09/30/2024 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0327-2024%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.